Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis
Conclusions
Patients with established gout such as those included in gout trials have a high burden of established morbidity and new diagnoses of morbid events. Consideration of comorbidities, which greatly exacerbate disease burden, is important in gout management.
Funding
AstraZeneca.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: AstraZeneca | Cardiology | Cardiovascular | Chronic Kidney Disease | Clinical Trials | Databases & Libraries | Drugs & Pharmacology | Gout | Heart | Heart Attack | Heart Disease | Hospital Management | Hypertension | Kidney Stones | Laboratory Medicine | Renal Failure | Statistics | Study | Urology & Nephrology